| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.6M | -41.7% |
| R&D Expense | $70.3M | -3.8% |
| SG&A Expense | $22.8M | -25.4% |
| Operating Income | -$89.2M | -1.2% |
| Pre-tax Income | -$130.9M | -50.6% |
| Income Tax | $331K | -58.4% |
| Net Income | -$131.2M | -49.6% |
| EPS (Basic) | -$20.94 | -1439.7% |
| EPS (Diluted) | -$20.94 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.0M | -72.7% |
| Short-term Investments | $19.9M | — |
| Current Assets | $62.1M | -56.0% |
| Total Assets | $70.1M | -53.7% |
| Current Liabilities | $21.7M | -9.1% |
| Total Liabilities | $99.1M | +66.6% |
| Stockholders' Equity | -$29.0M | -131.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$80.7M | -2.2% |
| Capital Expenditures | $130K | +584.2% |
| Investing Cash Flow | -$18.3M | -140.6% |
| Financing Cash Flow | $355K | -99.6% |
| Free Cash Flow | -$80.9M | -2.4% |
| -1439.7% |